Table 2 Prevalent cases, age-standardized prevalence rates, incident cases, age-standardized incidence rates, death cases, age-standardized mortality rates, DALYs, and age-standardized rates of DALYs for testicular cancer in 1990 and 2021 and rate change of age-standardized rates by Global Burden of Disease. DALYs: disability-adjusted life years.
From: Global burden and risk factors of male cancers from 1990 to 2021, with forecasts to 2040
1990 | 2021 | 1990–2021 | ||||
|---|---|---|---|---|---|---|
All-ages cases | Age-standardized rates per 100,000 | All-ages cases | Age-standardized rates per 100,000 | Rate change in age-standardized rates | ||
N (95%UI) | N (95%UI) | N (95%UI) | ||||
Global | Prevalence | 266,939 (258309 to 276080) | 9.99 (9.67 to 10.33) | 679,103 (651438 to 713930) | 16.59 (15.91 to 17.44) | 0.66 (0.57 to 0.75) |
Incidence | 38,833 (37572 to 40261) | 1.5 (1.45 to 1.55) | 91,507 (87966 to 95710) | 2.24 (2.16 to 2.35) | 0.5 (0.42 to 0.59) | |
Deaths | 7618 (7192 to 8076) | 0.33 (0.32 to 0.35) | 11,388 (10771 to 12056) | 0.29 (0.27 to 0.3) | -0.14 (-0.21 to -0.07) | |
DALYs | 389,817 (365899 to 413489) | 15.11 (14.2 to 16) | 560,921 (528325 to 597363) | 13.83 (13.03 to 14.73) | -0.08 (-0.16 to 0) | |
Socio-demographic Index (SDI) | ||||||
High SDI | Prevalence | 187,612 (181590 to 193773) | 38.83 (37.53 to 40.11) | 301,009 (289704 to 314194) | 53.24 (51.14 to 55.53) | 0.37 (0.3 to 0.45) |
Incidence | 22,264 (21596 to 22992) | 4.62 (4.48 to 4.76) | 34,234 (32897 to 35659) | 5.97 (5.74 to 6.22) | 0.29 (0.23 to 0.36) | |
Deaths | 1936 (1899 to 1972) | 0.41 (0.4 to 0.42) | 1668 (1601 to 1738) | 0.24 (0.23 to 0.25) | -0.42 (-0.44 to -0.4) | |
DALYs | 101,043 (96724 to 105565) | 21.04 (20.14 to 21.98) | 82,585 (76396 to 90296) | 13.83 (12.75 to 15.18) | -0.34 (-0.38 to -0.3) | |
High-middle SDI | Prevalence | 64,369 (59658 to 69420) | 11.05 (10.25 to 11.9) | 223,340 (205128 to 243627) | 32.42 (29.61 to 35.43) | 1.93 (1.58 to 2.27) |
Incidence | 9725 (9160 to 10359) | 1.74 (1.64 to 1.84) | 26,679 (24614 to 28913) | 3.83 (3.53 to 4.18) | 1.21 (0.97 to 1.45) | |
Deaths | 2137 (2011 to 2273) | 0.43 (0.41 to 0.46) | 2406 (2230 to 2593) | 0.32 (0.3 to 0.34) | -0.26 (-0.33 to -0.19) | |
DALYs | 103,900 (97041 to 110646) | 18.75 (17.54 to 19.97) | 109,438 (101410 to 119085) | 15.31 (14.15 to 16.67) | -0.18 (-0.26 to -0.1) | |
Middle SDI | Prevalence | 10,839 (9748 to 12156) | 1.21 (1.1 to 1.36) | 117,403 (107288 to 128723) | 9.02 (8.26 to 9.91) | 6.43 (5.41 to 7.55) |
Incidence | 4189 (3961 to 4443) | 0.52 (0.49 to 0.55) | 20,757 (19265 to 22331) | 1.62 (1.5 to 1.74) | 2.13 (1.85 to 2.43) | |
Deaths | 1912 (1787 to 2042) | 0.27 (0.25 to 0.29) | 3800 (3497 to 4104) | 0.31 (0.28 to 0.33) | 0.12 (0.02 to 0.24) | |
DALYs | 98,392 (92245 to 104764) | 11.69 (10.93 to 12.45) | 183,470 (169718 to 197745) | 14.33 (13.26 to 15.43) | 0.23 (0.11 to 0.34) | |
Low-middle SDI | Prevalence | 3112 (2551 to 3729) | 0.59 (0.49 to 0.7) | 30,124 (26129 to 34554) | 2.97 (2.58 to 3.4) | 4.03 (3.06 to 5.36) |
Incidence | 1990 (1666 to 2338) | 0.41 (0.34 to 0.48) | 7520 (6729 to 8438) | 0.77 (0.69 to 0.86) | 0.9 (0.53 to 1.4) | |
Deaths | 1206 (1000 to 1423) | 0.26 (0.22 to 0.31) | 2492 (2208 to 2820) | 0.28 (0.25 to 0.31) | 0.05 (-0.16 to 0.35) | |
DALYs | 63,854 (52805 to 75363) | 12.48 (10.33 to 14.76) | 130,174 (114505 to 148363) | 13.28 (11.74 to 15.1) | 0.06 (-0.16 to 0.38) | |
Low SDI | Prevalence | 654 (442 to 886) | 0.33 (0.22 to 0.44) | 6305 (4788 to 8038) | 1.24 (0.94 to 1.57) | 2.77 (1.85 to 4.16) |
Incidence | 610 (437 to 784) | 0.33 (0.24 to 0.42) | 2200 (1797 to 2609) | 0.47 (0.38 to 0.56) | 0.43 (0.15 to 0.81) | |
Deaths | 416 (300 to 536) | 0.24 (0.17 to 0.31) | 1011 (812 to 1203) | 0.24 (0.19 to 0.29) | 0 (-0.19 to 0.26) | |
DALYs | 22,044 (15762 to 28534) | 11.24 (8.08 to 14.46) | 54,695 (43962 to 65247) | 11.42 (9.15 to 13.61) | 0.02 (-0.19 to 0.29) | |
Regions | ||||||
Andean Latin America | Prevalence | 179 (98 to 325) | 1.03 (0.58 to 1.75) | 5039 (3491 to 6863) | 14.19 (9.91 to 19.37) | 12.8 (6.05 to 27.43) |
Incidence | 138 (103 to 181) | 0.84 (0.63 to 1.08) | 959 (729 to 1236) | 2.75 (2.1 to 3.55) | 2.28 (1.22 to 3.86) | |
Deaths | 73 (54 to 94) | 0.49 (0.37 to 0.63) | 193 (148 to 248) | 0.6 (0.46 to 0.78) | 0.23 (-0.12 to 0.74) | |
DALYs | 3826 (2817 to 5032) | 22.29 (16.49 to 29.15) | 9347 (7197 to 11766) | 27.1 (20.88 to 34.02) | 0.22 (-0.15 to 0.73) | |
Australasia | Prevalence | 6388 (5682 to 7210) | 58.16 (51.71 to 65.69) | 11,315 (9753 to 12983) | 72.85 (62.42 to 83.53) | 0.25 (0.03 to 0.48) |
Incidence | 740 (660 to 831) | 6.74 (6.01 to 7.59) | 1262 (1089 to 1444) | 8.06 (6.91 to 9.22) | 0.19 (-0.01 to 0.4) | |
Deaths | 52 (49 to 55) | 0.49 (0.46 to 0.52) | 43 (39 to 49) | 0.24 (0.21 to 0.27) | -0.52 (-0.56 to -0.45) | |
DALYs | 2848 (2613 to 3078) | 26.11 (23.97 to 28.23) | 2443 (2118 to 2853) | 15.09 (12.92 to 17.81) | -0.42 (-0.5 to -0.33) | |
Caribbean | Prevalence | 145 (108 to 185) | 0.82 (0.63 to 1.03) | 2051 (1714 to 2473) | 8.36 (6.99 to 10.08) | 9.21 (6.76 to 12.81) |
Incidence | 33 (29 to 37) | 0.19 (0.17 to 0.22) | 316 (266 to 369) | 1.29 (1.08 to 1.51) | 5.62 (4.4 to 7.07) | |
Deaths | 10 (9 to 11) | 0.07 (0.06 to 0.08) | 59 (51 to 69) | 0.24 (0.21 to 0.28) | 2.53 (1.93 to 3.2) | |
DALYs | 487 (440 to 554) | 2.89 (2.61 to 3.28) | 2354 (2007 to 2753) | 9.58 (8.17 to 11.21) | 2.32 (1.73 to 3.01) | |
Central Asia | Prevalence | 1262 (956 to 1687) | 3.82 (2.88 to 5.03) | 4482 (3682 to 5485) | 8.95 (7.41 to 10.95) | 1.35 (0.67 to 2.29) |
Incidence | 305 (254 to 374) | 1.1 (0.91 to 1.34) | 807 (685 to 967) | 1.78 (1.52 to 2.13) | 0.62 (0.26 to 1.12) | |
Deaths | 118 (98 to 139) | 0.52 (0.42 to 0.61) | 231 (197 to 275) | 0.62 (0.53 to 0.73) | 0.2 (-0.04 to 0.57) | |
DALYs | 5200 (4354 to 6223) | 18.61 (15.51 to 22.05) | 9345 (7974 to 11109) | 21.02 (17.95 to 24.93) | 0.13 (-0.11 to 0.47) | |
Central Europe | Prevalence | 15,546 (13967 to 17444) | 24.32 (21.83 to 27.36) | 40,453 (35926 to 45573) | 71.8 (63.67 to 80.75) | 1.95 (1.56 to 2.45) |
Incidence | 2597 (2425 to 2841) | 4.06 (3.79 to 4.44) | 5100 (4615 to 5689) | 8.74 (7.86 to 9.77) | 1.15 (0.9 to 1.44) | |
Deaths | 601 (569 to 642) | 0.96 (0.91 to 1.03) | 510 (467 to 555) | 0.73 (0.67 to 0.8) | -0.24 (-0.31 to -0.15) | |
DALYs | 29,348 (27608 to 31421) | 45.89 (43.14 to 49.15) | 22,588 (20501 to 24831) | 36.97 (33.49 to 40.77) | -0.19 (-0.28 to -0.11) | |
Central Latin America | Prevalence | 873 (741 to 1032) | 1.15 (0.98 to 1.35) | 18,747 (15510 to 22581) | 14.37 (11.93 to 17.27) | 11.51 (8.56 to 15.05) |
Incidence | 937 (893 to 980) | 1.26 (1.2 to 1.31) | 6322 (5745 to 6926) | 4.85 (4.4 to 5.31) | 2.86 (2.45 to 3.27) | |
Deaths | 389 (374 to 403) | 0.59 (0.57 to 0.61) | 1124 (1018 to 1233) | 0.89 (0.81 to 0.98) | 0.5 (0.35 to 0.65) | |
DALYs | 21,418 (20602 to 22216) | 27.95 (26.91 to 28.91) | 61,219 (55574 to 66762) | 47.04 (42.69 to 51.33) | 0.68 (0.52 to 0.85) | |
Central Sub-Saharan Africa | Prevalence | 49 (29 to 79) | 0.25 (0.16 to 0.38) | 567 (336 to 916) | 0.94 (0.57 to 1.47) | 2.82 (1.12 to 5.62) |
Incidence | 53 (37 to 70) | 0.31 (0.22 to 0.41) | 224 (154 to 311) | 0.47 (0.33 to 0.65) | 0.52 (0.04 to 1.16) | |
Deaths | 39 (27 to 52) | 0.26 (0.19 to 0.36) | 122 (85 to 168) | 0.32 (0.22 to 0.45) | 0.21 (-0.17 to 0.74) | |
DALYs | 1962 (1350 to 2627) | 10.03 (7.03 to 13.28) | 6213 (4269 to 8685) | 11.99 (8.37 to 16.42) | 0.2 (-0.18 to 0.76) | |
East Asia | Prevalence | 5664 (4734 to 6690) | 0.87 (0.72 to 1.02) | 55,673 (44144 to 70209) | 6.61 (5.27 to 8.22) | 6.64 (4.59 to 9.19) |
Incidence | 1996 (1670 to 2341) | 0.35 (0.29 to 0.41) | 7090 (5597 to 9025) | 0.84 (0.67 to 1.06) | 1.43 (0.78 to 2.21) | |
Deaths | 1078 (889 to 1269) | 0.22 (0.18 to 0.26) | 1286 (1003 to 1621) | 0.15 (0.12 to 0.19) | -0.31 (-0.49 to -0.08) | |
DALYs | 51,003 (42182 to 60108) | 8.17 (6.75 to 9.6) | 46,546 (36156 to 58274) | 5.58 (4.36 to 6.96) | -0.32 (-0.5 to -0.08) | |
Eastern Europe | Prevalence | 15,368 (14203 to 16520) | 13.24 (12.23 to 14.18) | 35,610 (32793 to 38253) | 32.78 (30.26 to 35.11) | 1.48 (1.22 to 1.77) |
Incidence | 2373 (2183 to 2547) | 2.09 (1.93 to 2.24) | 4538 (4151 to 4897) | 4.14 (3.79 to 4.47) | 0.98 (0.75 to 1.24) | |
Deaths | 579 (525 to 626) | 0.55 (0.5 to 0.59) | 539 (473 to 602) | 0.47 (0.41 to 0.52) | -0.14 (-0.26 to 0) | |
DALYs | 27,266 (24778 to 29546) | 24.07 (21.93 to 25.99) | 24,718 (21766 to 27656) | 22.46 (19.82 to 25.08) | -0.07 (-0.19 to 0.09) | |
Eastern Sub-Saharan Africa | Prevalence | 233 (156 to 315) | 0.32 (0.22 to 0.43) | 2921 (2099 to 3871) | 1.5 (1.1 to 1.95) | 3.67 (2.19 to 5.66) |
Incidence | 219 (155 to 283) | 0.33 (0.24 to 0.43) | 1067 (839 to 1323) | 0.61 (0.48 to 0.76) | 0.83 (0.39 to 1.44) | |
Deaths | 154 (108 to 202) | 0.25 (0.17 to 0.33) | 517 (403 to 644) | 0.33 (0.26 to 0.41) | 0.3 (-0.01 to 0.73) | |
DALYs | 8294 (5779 to 10946) | 11.76 (8.21 to 15.38) | 28,574 (22166 to 35673) | 15.79 (12.36 to 19.66) | 0.34 (0.01 to 0.79) | |
High-income Asia Pacific | Prevalence | 20,539 (18067 to 23356) | 22.17 (19.46 to 25.23) | 25,339 (23085 to 27726) | 29.42 (26.66 to 32.2) | 0.33 (0.14 to 0.55) |
Incidence | 2392 (2133 to 2702) | 2.58 (2.29 to 2.91) | 2862 (2619 to 3130) | 3.25 (2.94 to 3.56) | 0.26 (0.08 to 0.46) | |
Deaths | 172 (165 to 179) | 0.19 (0.18 to 0.2) | 124 (116 to 130) | 0.1 (0.09 to 0.1) | -0.49 (-0.51 to -0.45) | |
DALYs | 9715 (9109 to 10340) | 10.5 (9.84 to 11.19) | 5888 (5327 to 6577) | 6.17 (5.52 to 6.96) | -0.41 (-0.46 to -0.36) | |
High-income North America | Prevalence | 67,947 (65454 to 70470) | 43.76 (42.18 to 45.36) | 121,849 (116600 to 127621) | 66.89 (63.92 to 70.21) | 0.53 (0.44 to 0.62) |
Incidence | 7763 (7494 to 8047) | 5.01 (4.83 to 5.19) | 13,696 (13112 to 14330) | 7.45 (7.12 to 7.82) | 0.49 (0.41 to 0.57) | |
Deaths | 496 (485 to 508) | 0.33 (0.32 to 0.33) | 596 (572 to 616) | 0.28 (0.27 to 0.29) | -0.13 (-0.16 to -0.1) | |
DALYs | 28,089 (26685 to 29921) | 18.21 (17.31 to 19.4) | 32,858 (30334 to 35879) | 17.42 (16.04 to 19.08) | -0.04 (-0.09 to 0) | |
North Africa and Middle East | Prevalence | 13,966 (10772 to 17781) | 8.73 (6.75 to 11.06) | 108,001 (91432 to 126298) | 31.52 (26.57 to 36.74) | 2.61 (1.71 to 3.86) |
Incidence | 1710 (1335 to 2165) | 1.1 (0.87 to 1.38) | 12,009 (10180 to 14046) | 3.55 (3 to 4.13) | 2.22 (1.41 to 3.32) | |
Deaths | 228 (183 to 283) | 0.19 (0.15 to 0.23) | 467 (403 to 539) | 0.17 (0.15 to 0.2) | -0.08 (-0.28 to 0.18) | |
DALYs | 12,572 (10039 to 15569) | 8.45 (6.77 to 10.34) | 27,387 (23389 to 32355) | 8.43 (7.21 to 9.96) | 0 (-0.24 to 0.31) | |
Oceania | Prevalence | 16 (10 to 24) | 0.52 (0.35 to 0.74) | 50 (35 to 69) | 0.74 (0.53 to 0.99) | 0.4 (-0.14 to 1.19) |
Incidence | 7 (5 to 9) | 0.29 (0.21 to 0.38) | 16 (13 to 20) | 0.3 (0.24 to 0.38) | 0.04 (-0.24 to 0.42) | |
Deaths | 3 (2 to 5) | 0.2 (0.14 to 0.27) | 8 (6 to 10) | 0.19 (0.15 to 0.24) | -0.07 (-0.32 to 0.33) | |
DALYs | 167 (115 to 225) | 6.4 (4.55 to 8.49) | 342 (267 to 434) | 5.86 (4.66 to 7.48) | -0.08 (-0.32 to 0.24) | |
South Asia | Prevalence | 3640 (2904 to 4432) | 0.69 (0.55 to 0.84) | 35,936 (30364 to 42548) | 3.49 (2.96 to 4.13) | 4.06 (2.87 to 5.65) |
Incidence | 2476 (2042 to 2925) | 0.5 (0.42 to 0.6) | 8349 (7202 to 9574) | 0.84 (0.73 to 0.96) | 0.67 (0.29 to 1.16) | |
Deaths | 1520 (1245 to 1803) | 0.33 (0.27 to 0.39) | 2753 (2356 to 3176) | 0.3 (0.25 to 0.34) | -0.1 (-0.31 to 0.18) | |
DALYs | 81,325 (66477 to 96213) | 15.94 (13.06 to 18.86) | 144,761 (123483 to 166639) | 14.54 (12.42 to 16.73) | -0.09 (-0.3 to 0.2) | |
Southeast Asia | Prevalence | 2236 (1707 to 2793) | 0.98 (0.76 to 1.22) | 18,267 (14816 to 21888) | 4.83 (3.92 to 5.79) | 3.94 (2.65 to 5.63) |
Incidence | 783 (691 to 899) | 0.39 (0.35 to 0.45) | 3181 (2621 to 3811) | 0.87 (0.72 to 1.04) | 1.2 (0.78 to 1.64) | |
Deaths | 359 (317 to 412) | 0.21 (0.18 to 0.24) | 818 (677 to 1008) | 0.24 (0.2 to 0.3) | 0.18 (-0.04 to 0.44) | |
DALYs | 18,197 (16035 to 20999) | 8.84 (7.8 to 10.18) | 38,006 (31288 to 47440) | 10.38 (8.56 to 12.85) | 0.18 (-0.06 to 0.45) | |
Southern Latin America | Prevalence | 4851 (3818 to 6151) | 19.93 (15.72 to 25.2) | 29,440 (25246 to 34164) | 83.38 (71.41 to 96.87) | 3.18 (2.23 to 4.53) |
Incidence | 858 (736 to 1001) | 3.59 (3.09 to 4.17) | 3566 (3111 to 4087) | 10.07 (8.76 to 11.55) | 1.81 (1.36 to 2.42) | |
Deaths | 250 (220 to 280) | 1.09 (0.96 to 1.22) | 385 (344 to 424) | 1.07 (0.96 to 1.18) | -0.01 (-0.13 to 0.12) | |
DALYs | 13,059 (11366 to 14792) | 54.56 (47.59 to 61.62) | 20,275 (17925 to 22674) | 57.05 (50.44 to 63.79) | 0.05 (-0.1 to 0.22) | |
Southern Sub-Saharan Africa | Prevalence | 221 (168 to 277) | 0.99 (0.77 to 1.22) | 1095 (898 to 1331) | 2.61 (2.15 to 3.15) | 1.64 (0.96 to 2.52) |
Incidence | 110 (90 to 129) | 0.64 (0.52 to 0.74) | 308 (266 to 356) | 0.88 (0.77 to 1.01) | 0.39 (0.16 to 0.74) | |
Deaths | 62 (51 to 72) | 0.45 (0.36 to 0.52) | 128 (111 to 147) | 0.46 (0.41 to 0.53) | 0.04 (-0.13 to 0.32) | |
DALYs | 2641 (2166 to 3089) | 14.18 (11.66 to 16.53) | 5520 (4769 to 6399) | 15.49 (13.53 to 17.84) | 0.09 (-0.09 to 0.37) | |
Tropical Latin America | Prevalence | 1255 (963 to 1570) | 1.65 (1.28 to 2.07) | 14,858 (12797 to 17096) | 12.38 (10.66 to 14.28) | 6.5 (4.69 to 8.92) |
Incidence | 545 (510 to 586) | 0.77 (0.72 to 0.82) | 2907 (2645 to 3161) | 2.44 (2.22 to 2.65) | 2.17 (1.85 to 2.53) | |
Deaths | 224 (211 to 238) | 0.35 (0.33 to 0.38) | 573 (527 to 613) | 0.49 (0.45 to 0.52) | 0.38 (0.27 to 0.49) | |
DALYs | 11,754 (11082 to 12462) | 16.29 (15.34 to 17.28) | 29,228 (26847 to 31324) | 24.55 (22.55 to 26.32) | 0.51 (0.39 to 0.63) | |
Western Europe | Prevalence | 106,426 (101588 to 111832) | 52.25 (49.84 to 54.98) | 146,456 (136280 to 157946) | 69.23 (64.39 to 74.99) | 0.32 (0.22 to 0.46) |
Incidence | 12,685 (12105 to 13313) | 6.19 (5.91 to 6.51) | 16,571 (15454 to 17836) | 7.69 (7.15 to 8.32) | 0.24 (0.14 to 0.36) | |
Deaths | 1137 (1103 to 1170) | 0.54 (0.52 to 0.55) | 744 (689 to 801) | 0.25 (0.24 to 0.27) | -0.53 (-0.56 to -0.5) | |
DALYs | 56,699 (53748 to 59859) | 27.42 (25.97 to 29) | 34,189 (30686 to 38494) | 14.71 (13.07 to 16.69) | -0.46 (-0.51 to -0.41) | |
Western Sub-Saharan Africa | Prevalence | 137 (100 to 182) | 0.17 (0.13 to 0.23) | 952 (689 to 1241) | 0.46 (0.34 to 0.6) | 1.63 (0.82 to 2.75) |
Incidence | 113 (92 to 136) | 0.16 (0.13 to 0.19) | 357 (276 to 445) | 0.19 (0.15 to 0.24) | 0.21 (-0.05 to 0.58) | |
Deaths | 75 (61 to 89) | 0.11 (0.09 to 0.13) | 169 (134 to 211) | 0.1 (0.08 to 0.13) | -0.11 (-0.31 to 0.15) | |
DALYs | 3948 (3198 to 4703) | 5.17 (4.2 to 6.14) | 9121 (7179 to 11346) | 4.74 (3.75 to 5.92) | -0.08 (-0.28 to 0.19) | |
